Clinical trials
beta-Thalassemia trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Novartis Pharmaceuticals | 3 |
| Shire | 2 |
| Abfero Pharmaceuticals, Inc | 1 |
| Ankara City Hospital Bilkent | 1 |
| Ataturk University | 1 |
| Cerus Corporation | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Istanbul University | 1 |
| La Jolla Pharmaceutical Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 18 |
| Iron Overload | 7 |
| Thalassemia | 4 |
| Anemia, Sickle Cell | 2 |
| Breast Neoplasms | 1 |
| Cardiotoxicity | 1 |
| Fatigue | 1 |
| Heart Diseases | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.